Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Oliver Schönborn-Kellenberger
Cogitars GmbH
Germany
Contact
Cogitars GmbH
Email
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
1,572
TOTAL CITATIONS
9
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Efficacy and Safety of the CVnCoV SARS-CoV-2 mRNA Vaccine Candidate: Results from Herald, a Phase 2b/3, Randomised, Observer-Blinded, Placebo-Controlled Clinical Trial in Ten Countries in Europe and Latin America
Number of pages: 29
Posted: 27 Aug 2021
Peter G. Kremsner
,
Rodolfo Andrés Ahuad Guerrero
,
Eunate Arana
,
Gustavo Jose Aroca Martinez
,
Marc J.M. Bonten
,
Reynaldo Chandler
,
Gonzalo Corral
,
Eddie Jan Louis De Block
,
Lucie Ecker
,
Julian Justin Gabor
,
Carlos Alberto Garcia Lopez
,
Lucy Gonzales
,
María Angélica Granados González
,
Nestor Gorini
,
Martin P. Grobusch
,
Martin P. Grobusch
,
Adrian D. Hrabar
,
Helga Junker
,
Alan Kimura
,
Claudio F. Lanata
,
Clara Lehmann
,
Isabel Leroux-Roels
,
Philipp Mann
,
Michel Fernando Martinez-Reséndez
,
Theresa Ochoa
,
Carlos Alberto Poy
,
Maria Jose Reyes Fentanes
,
Luis Maria Rivera Mejia
,
Vida Veronica Ruiz Herrera
,
Xavier Sáez-Llorens
, Oliver Schönborn-Kellenberger,
Mirjam Schunk
,
Alexandra Sierra Garcia
,
Itziar Vergara
,
Thomas Verstraeten
,
Marisa Vico
,
Lidia Oostvogels
and
HERALD Study Group
Lambaréné Medical Research Center (CERMEL), Lambaréné, Corporacion Medica de General San Martin, University of the Basque Country - Biocruces Bizkaia Health Research Institute, Universidad Simón Bolívar (USB) - Clínica de la Costa, Utrecht University - Julius Center for Health Sciences and Primary Care, Cevaxin, Instituto de Investigaciones Clinicas de Mar del Plata, Cohezio, Instituto de Investigación Nutricional, University of Tübingen - Institute of Tropical Medicine, Unidad de Medicina Especializada, Clinica Medica San Martin, Centro de Atención e Investigación Médica (CAIMED), Hospital Zonal General de Agudos Descentralizado Evita Pueblo de Berazategui, Lambaréné Medical Research Center (CERMEL), LambarénéUniversity of Amsterdam - Amsterdam Institute for Infection and Immunity, Clinical Research Institute Quilmes (Instituto de Investigaciones Clínicas Quilmes), CureVac AG, CureVac AG, Instituto de Investigación Nutricional, University of Cologne - Division of Infectious Diseases, Ghent University - Center for Vaccinology (CEVAC), CureVac AG, TecSalud - School of Medicine and Health Sciences, Universidad Peruana Cayetano Heredia - Instituto de Medicina Tropical Alexander von Humboldt, Sanatorio Parque S.A. Rosario, PanAmerican Clinical Research, Hospital Universitario Maternidad Nuestra Señora de La Altagracia - Fundacion Dominicana de Perinatologia PRO-BEBE, Inc., PanAmerican Clinical Research, Hospital del Niño Dr. José Renán Esquivel, Cogitars GmbH, Ludwig Maximilian University of Munich (LMU) - Division of Infectious Diseases and Tropical Medicine, Centro de estudios en Infectologia Pediatrica (CEIP), Biodonostia Health Research Institute - Primary Care Group, P95 Pharmacovigilance and Epidemiology Services, Instituto de Investigaciones Clínicas Zárate, CureVac AG and Independent
Downloads
1,572
(29,255)
Citation
9
View PDF
Download
Abstract:
CVnCoV mRNA vaccine; SARS-CoV-2; COVID-19; adults; randomised clinical trial
Feedback